4
Changes in Ownership
Black Diamond Therapeutics, Inc. Filed Acc 0001415889-22-009773
Director acquired 4,294 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Velleca Mark A. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-09-16 | Grant or award : show line 1 in the form | +4,294 | $2.62 | $11,250 | 12,733 | D |
Loading xslF345X03/form4-09192022_020914.xml…